Home·Stocks·AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock

AMRX

XNAS

Amneal Pharmaceuticals, Inc. Class A Common Stock

Basic Materials · Pharmaceutical Preparations

$13.10
+0.15 (+1.16%)
15-min delayed

Drag to pan · Scroll to zoom · Hover for OHLC

Snapshot
Loading metrics…
About Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Employees
8,500
Country
US
IPO Date
2018-05-07
www.amneal.com
Recent News
No recent news
COMMUNITY · $AMRX0 theses
POST YOUR TAKE →
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…

Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.

AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock Stock — $13.10 +1.16% · AlgoThesis